US-Iran Reach Preliminary Peace Deal as Israel Vows to Maintain “Security Zones”

Key Takeaways

  • US and Iran have reached a preliminary "Islamabad Memorandum of Understanding" (MOU) to end their conflict and reopen the Strait of Hormuz, triggering a 5% drop in global oil prices.
  • Israel has officially rejected withdrawal from Lebanon, with Defense Minister Israel Katz stating the IDF will maintain an indefinite presence in "security zones" across Lebanon, Syria, and Gaza.
  • India's Wholesale Price Index (WPI) surged to 9.68% in May, significantly exceeding analyst estimates of 9.55% as energy costs from the regional conflict continue to impact domestic inflation.
  • Switzerland's Producer and Import Prices fell 0.4% in May, driven by lower costs for petroleum and pharmaceutical products, bringing the annual rate to -1.8%.
  • Eisai (4523) announced a strategic investment in its UK manufacturing site, supported by the government’s Life Sciences Innovative Manufacturing Fund (LSIMF) to enhance cold-chain medicine capabilities.

US-Iran Peace Framework and Market Impact

In a major geopolitical breakthrough, US President Donald Trump announced that a Pakistan-mediated agreement, the Islamabad Memorandum of Understanding, has been finalized to end the ongoing war with Iran. The deal, scheduled for a formal signing this Friday in Switzerland, stipulates an immediate cessation of hostilities and the lifting of the naval blockade on the Strait of Hormuz. Oil markets reacted sharply to the news, with Brent crude futures falling approximately 5% as traders priced in the restoration of freedom of navigation in the world's most critical energy chokepoint.

Despite the diplomatic progress, the MOU leaves several high-stakes issues unresolved, including the future of Tehran’s nuclear program. Kuwait and the European Union have welcomed the development, with EU officials indicating they may expand Operation Aspides to assist in demining the Strait. However, hardline factions within Iran have already expressed skepticism, warning that the waterway should only reopen once all US forces have exited the region.

Israel Defies Withdrawal Pressures

While Washington and Tehran move toward a ceasefire, Israel has signaled it will not be bound by any clauses requiring a military withdrawal from Lebanon. Defense Minister Israel Katz confirmed that Prime Minister Benjamin Netanyahu communicated this stance directly to President Trump, emphasizing that the IDF will remain in strategic buffer zones to "thwart the threat from Hezbollah." The Israeli cabinet remains unified in its policy of maintaining "security zones" in Lebanon, Syria, and Gaza, viewing these territories as essential achievements of the conflict.

The Defense Minister further warned that any Iranian retaliation linked to developments in Lebanon would be met with "maximum, unmitigated power" against Iranian sovereign infrastructure. This hardline stance comes even as Ukraine’s President Zelenskiy calls on G7 nations to increase pressure on Russia and bolster Kyiv's air defenses, highlighting the overlapping security crises currently straining Western military resources.

Global Economic Data and Corporate Developments

In economic news, India’s wholesale inflation accelerated to 9.68% in May, up from 8.26% the previous month. The spike was largely attributed to the lingering effects of the Middle East conflict on fuel and global supply chains, even as the government introduced a revamped WPI series with a 2022-23 base year. Conversely, Switzerland reported a continued deflationary trend in producer prices, which fell 1.8% year-on-year, providing some relief to the Swiss National Bank ahead of upcoming policy meetings.

On the corporate front, Japanese pharmaceutical giant Eisai (4523) is expanding its footprint in the United Kingdom. The company’s investment in its Hatfield manufacturing site is aimed at establishing in-house capabilities for advanced medicines requiring specialized cold-chain management. This move is part of a broader UK government initiative to attract transformational life sciences investment through the LSIMF and the newly launched Life Sciences Large Investment Portfolio.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top